- call +1-201-465-4211
- email sales@mrinsights.biz
Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.
Scope of the Report:
The classification of Flu Vaccine includes Whole Virus Vaccines, Split Virus Vaccines, Subunit Vaccines and Live Attenuated Virus Vaccines, and the proportion of Whole Virus Vaccines in 2016 is about 43%, and the proportion is in decreasing trend from 2012 to 2016.
Flu Vaccine is widely used for Children (6 months to 3 years) and for Adults and Children over 3 years. The most proportion of Flu Vaccine is For Adults and Children over 3 years, and the proportion in 2016 is about 75%.
The Europe in the EMEA is the largest consumption place, with a consumption market share nearly 80% in 2016. And in the major countries we mentioned in the report, Germany is the largest consumption place with the consumption market share of 12%. Following Russia, France is the second largest consumption region, with the proportion of 11%.
The worldwide market for Flu Vaccine (Influenza Vaccine) is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new study.
This report focuses on the Flu Vaccine (Influenza Vaccine) in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
CSL
GSK
Sanofi Pasteur
Mylan
AstraZeneca
Pfizer
Johnson & Johnson
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Whole Virus Vaccines
Split Virus Vaccines
Subunit Vaccines
Live Attenuated Virus Vaccines
Market Segment by Applications, can be divided into
For Children (6 months to 3 years)
For Adults and Children over 3 years
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Flu Vaccine (Influenza Vaccine) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Flu Vaccine (Influenza Vaccine), with price, sales, revenue and global market share of Flu Vaccine (Influenza Vaccine) in 2017 and 2018.
Chapter 3, the Flu Vaccine (Influenza Vaccine) competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Flu Vaccine (Influenza Vaccine) breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Flu Vaccine (Influenza Vaccine) market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Flu Vaccine (Influenza Vaccine) sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Flu Vaccine (Influenza Vaccine) Introduction
1.2 Market Analysis by Type
1.2.1 Whole Virus Vaccines
1.2.2 Split Virus Vaccines
1.2.3 Subunit Vaccines
1.2.4 Live Attenuated Virus Vaccines
1.3 Market Analysis by Applications
1.3.1 For Children (6 months to 3 years)
1.3.2 For Adults and Children over 3 years
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 CSL
2.1.1 Business Overview
2.1.2 Flu Vaccine (Influenza Vaccine) Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 CSL Flu Vaccine (Influenza Vaccine) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 GSK
2.2.1 Business Overview
2.2.2 Flu Vaccine (Influenza Vaccine) Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 GSK Flu Vaccine (Influenza Vaccine) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 Sanofi Pasteur
2.3.1 Business Overview
2.3.2 Flu Vaccine (Influenza Vaccine) Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Sanofi Pasteur Flu Vaccine (Influenza Vaccine) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Mylan
2.4.1 Business Overview
2.4.2 Flu Vaccine (Influenza Vaccine) Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Mylan Flu Vaccine (Influenza Vaccine) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 AstraZeneca
2.5.1 Business Overview
2.5.2 Flu Vaccine (Influenza Vaccine) Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 AstraZeneca Flu Vaccine (Influenza Vaccine) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 Pfizer
2.6.1 Business Overview
2.6.2 Flu Vaccine (Influenza Vaccine) Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Pfizer Flu Vaccine (Influenza Vaccine) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.7 Johnson & Johnson
2.7.1 Business Overview
2.7.2 Flu Vaccine (Influenza Vaccine) Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Johnson & Johnson Flu Vaccine (Influenza Vaccine) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Flu Vaccine (Influenza Vaccine) Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Flu Vaccine (Influenza Vaccine) Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Flu Vaccine (Influenza Vaccine) Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Flu Vaccine (Influenza Vaccine) Manufacturer Market Share in 2018
3.3.2 Top 6 Flu Vaccine (Influenza Vaccine) Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Flu Vaccine (Influenza Vaccine) Market Analysis by Regions
4.1 Global Flu Vaccine (Influenza Vaccine) Sales, Revenue and Market Share by Regions
4.1.1 Global Flu Vaccine (Influenza Vaccine) Sales and Market Share by Regions (2014-2019)
4.1.2 Global Flu Vaccine (Influenza Vaccine) Revenue and Market Share by Regions (2014-2019)
4.2 North America Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2014-2019)
4.3 Europe Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2014-2019)
4.5 South America Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2014-2019)
5 North America Flu Vaccine (Influenza Vaccine) by Country
5.1 North America Flu Vaccine (Influenza Vaccine) Sales, Revenue and Market Share by Country
5.1.1 North America Flu Vaccine (Influenza Vaccine) Sales and Market Share by Country (2014-2019)
5.1.2 North America Flu Vaccine (Influenza Vaccine) Revenue and Market Share by Country (2014-2019)
5.2 United States Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2014-2019)
5.3 Canada Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2014-2019)
5.4 Mexico Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2014-2019)
6 Europe Flu Vaccine (Influenza Vaccine) by Country
6.1 Europe Flu Vaccine (Influenza Vaccine) Sales, Revenue and Market Share by Country
6.1.1 Europe Flu Vaccine (Influenza Vaccine) Sales and Market Share by Country (2014-2019)
6.1.2 Europe Flu Vaccine (Influenza Vaccine) Revenue and Market Share by Country (2014-2019)
6.2 Germany Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2014-2019)
6.3 UK Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2014-2019)
6.4 France Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2014-2019)
6.5 Russia Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2014-2019)
6.6 Italy Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2014-2019)
7 Asia-Pacific Flu Vaccine (Influenza Vaccine) by Country
7.1 Asia-Pacific Flu Vaccine (Influenza Vaccine) Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Flu Vaccine (Influenza Vaccine) Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Flu Vaccine (Influenza Vaccine) Revenue and Market Share by Country (2014-2019)
7.2 China Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2014-2019)
7.3 Japan Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2014-2019)
7.4 Korea Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2014-2019)
7.5 India Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2014-2019)
8 South America Flu Vaccine (Influenza Vaccine) by Country
8.1 South America Flu Vaccine (Influenza Vaccine) Sales, Revenue and Market Share by Country
8.1.1 South America Flu Vaccine (Influenza Vaccine) Sales and Market Share by Country (2014-2019)
8.1.2 South America Flu Vaccine (Influenza Vaccine) Revenue and Market Share by Country (2014-2019)
8.2 Brazil Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2014-2019)
8.3 Argentina Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2014-2019)
8.4 Colombia Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2014-2019)
9 Middle East and Africa Flu Vaccine (Influenza Vaccine) by Countries
9.1 Middle East and Africa Flu Vaccine (Influenza Vaccine) Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Flu Vaccine (Influenza Vaccine) Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Flu Vaccine (Influenza Vaccine) Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2014-2019)
9.3 Turkey Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2014-2019)
9.4 Egypt Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2014-2019)
9.5 Nigeria Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2014-2019)
9.6 South Africa Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2014-2019)
10 Global Flu Vaccine (Influenza Vaccine) Market Segment by Type
10.1 Global Flu Vaccine (Influenza Vaccine) Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Flu Vaccine (Influenza Vaccine) Sales and Market Share by Type (2014-2019)
10.1.2 Global Flu Vaccine (Influenza Vaccine) Revenue and Market Share by Type (2014-2019)
10.2 Whole Virus Vaccines Sales Growth and Price
10.2.1 Global Whole Virus Vaccines Sales Growth (2014-2019)
10.2.2 Global Whole Virus Vaccines Price (2014-2019)
10.3 Split Virus Vaccines Sales Growth and Price
10.3.1 Global Split Virus Vaccines Sales Growth (2014-2019)
10.3.2 Global Split Virus Vaccines Price (2014-2019)
10.4 Subunit Vaccines Sales Growth and Price
10.4.1 Global Subunit Vaccines Sales Growth (2014-2019)
10.4.2 Global Subunit Vaccines Price (2014-2019)
10.5 Live Attenuated Virus Vaccines Sales Growth and Price
10.5.1 Global Live Attenuated Virus Vaccines Sales Growth (2014-2019)
10.5.2 Global Live Attenuated Virus Vaccines Price (2014-2019)
11 Global Flu Vaccine (Influenza Vaccine) Market Segment by Application
11.1 Global Flu Vaccine (Influenza Vaccine) Sales Market Share by Application (2014-2019)
11.2 For Children (6 months to 3 years) Sales Growth (2014-2019)
11.3 For Adults and Children over 3 years Sales Growth (2014-2019)
12 Flu Vaccine (Influenza Vaccine) Market Forecast (2019-2024)
12.1 Global Flu Vaccine (Influenza Vaccine) Sales, Revenue and Growth Rate (2019-2024)
12.2 Flu Vaccine (Influenza Vaccine) Market Forecast by Regions (2019-2024)
12.2.1 North America Flu Vaccine (Influenza Vaccine) Market Forecast (2019-2024)
12.2.2 Europe Flu Vaccine (Influenza Vaccine) Market Forecast (2019-2024)
12.2.3 Asia-Pacific Flu Vaccine (Influenza Vaccine) Market Forecast (2019-2024)
12.2.4 South America Flu Vaccine (Influenza Vaccine) Market Forecast (2019-2024)
12.2.5 Middle East and Africa Flu Vaccine (Influenza Vaccine) Market Forecast (2019-2024)
12.3 Flu Vaccine (Influenza Vaccine) Market Forecast by Type (2019-2024)
12.3.1 Global Flu Vaccine (Influenza Vaccine) Sales Forecast by Type (2019-2024)
12.3.2 Global Flu Vaccine (Influenza Vaccine) Market Share Forecast by Type (2019-2024)
12.4 Flu Vaccine (Influenza Vaccine) Market Forecast by Application (2019-2024)
12.4.1 Global Flu Vaccine (Influenza Vaccine) Sales Forecast by Application (2019-2024)
12.4.2 Global Flu Vaccine (Influenza Vaccine) Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Flu Vaccine (Influenza Vaccine) Picture
Table Product Specifications of Flu Vaccine (Influenza Vaccine)
Figure Global Sales Market Share of Flu Vaccine (Influenza Va
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
